Low LDL Target, No Clinical Gain in Non-CAD Diabetes: EMPATHY

Statins aimed at reducing LDL-C to less than 70 mg/dL didn’t cut cardiovascular events, but an intriguing post hoc finding suggests there may yet be benefit, in this trial of patients with diabetic retinopathy.
Medscape Medical News

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.

Be the first to comment

Leave a Reply